Quantum Genomics (Quantum Genomics) Change In Receivables : $-5.49 Mil (TTM As of Dec. 2022)

View and export this data going back to 2017. Start your Free Trial

What is Quantum Genomics Change In Receivables?

Quantum Genomics's change in receivables for the quarter that ended in Dec. 2022 was $-6.31 Mil. It means Quantum Genomics's Accounts Receivable increased by $6.31 Mil from Jun. 2022 to Dec. 2022 .

Quantum Genomics's change in receivables for the fiscal year that ended in Dec. 2022 was $-5.49 Mil. It means Quantum Genomics's Accounts Receivable increased by $5.49 Mil from Dec. 2021 to Dec. 2022 .

Quantum Genomics's Accounts Receivable for the quarter that ended in Dec. 2022 was $0.00 Mil.

Days Sales Outstanding measures of the average number of days that a company takes to collect revenue after a sale has been made. It is a financial ratio that illustrates how well a company's Accounts Receivable are being managed.

In Ben Graham's calculation of liquidation value, Apple Inc's Accounts Receivable are only considered to be worth 75% of book value. Quantum Genomics's liquidation value for the six months ended in Dec. 2022 was $-10.18 Mil.

Quantum Genomics Change In Receivables Historical Data

The historical data trend for Quantum Genomics's Change In Receivables can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Quantum Genomics Change In Receivables Chart

Quantum Genomics Annual Data

Trend

Dec13

Dec14

Dec15

Dec16

Dec17

Dec18

Dec19

Dec20

Dec21

Dec22

Change In Receivables

Get a 7-Day Free Trial

-0.49

-0.26

-1.00

-5.49

Quantum Genomics Semi-Annual Data
	Jun13	Dec13	Jun14	Dec14	Jun15	Dec15	Jun16	Dec16	Jun17	Dec17	Jun18	Dec18	Jun19	Dec19	Jun20	Dec20	Jun21	Dec21	Jun22	Dec22
Change In Receivables	Get a 7-Day Free Trial															-1.55	-0.47	-	0.82	-6.31

Quantum Genomics Change In Receivables Calculation

Change In Accounts Receivable relative to the previous period. It is any increase or decrease in the cash a company is owed by its customers.

Change In Receivables for the trailing twelve months (TTM) ended in Dec. 2022 adds up the semi-annually data reported by the company within the most recent 12 months, which was $-5.49 Mil.

Quantum Genomics (OTCPK:QNNTF) Change In Receivables Explanation

1. Accounts Receivable are created when a customer has received a product but has not yet paid for that product. Days Sales Outstanding measures of the average number of days that a company takes to collect revenue after a sale has been made. It is a financial ratio that illustrates how well a company's Accounts Receivable are being managed.

Quantum Genomics's Days Sales Outstanding for the quarter that ended in Dec. 2022 is calculated as:

	Days Sales Outstanding
=	Accounts Receivable	/	Revenue	*	Days in Period
=	0	/	-0.309	*	91
=

2. In Ben Graham's calculation of liquidation value, Quantum Genomics's accounts receivable are only considered to be worth 75% of book value:

Quantum Genomics's liquidation value for the quarter that ended in Dec. 2022 is calculated as:

	Liquidation Value
=	Cash, Cash Equivalents, Marketable Securities	-	Total Liabilities	+	(0.75 * Accounts Receivable)	+	(0.5 * Total Inventories)
=	11.018	-	21.197	+	0.75 * 0	+	0.5 * 0
=	-10.18

Quantum Genomics Change In Receivables Related Terms

Thank you for viewing the detailed overview of Quantum Genomics's Change In Receivables provided by GuruFocus.com. Please click on the following links to see related term pages.

Quantum Genomics (Quantum Genomics) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Quantum Genomics (OTCPK:QNNTF) » Definitions » Change In Receivables

Comparable Companies

Traded in Other Exchanges

ALQGC:France 2QG:Germany

Address

33, Rue Marbeuf, Paris, FRA, 75008

Website

https://quantum-genomics.com

Quantum Genomics is a biopharmaceutical company engaged in developing new products for unmet needs in the field of cardiovascular diseases, high blood pressure, and heart failure. The company products include firibastat, QGC006, QGC011, and others.